Revenue increased 37.9%
Revenue changed +37.9% from the comparable as-filed period.
$309.9M→$427.3M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RBRK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 1366 bp higher
Operating margin changed +1366 basis points from the comparable as-filed period.
-30.49%→-16.83%2 prior comparisons
Net income increased 35.6%
Net income changed +35.6% from the comparable as-filed period.
-$95.9M→-$61.8M2 prior comparisons
Cash & equivalents increased 29.0%
Cash & equivalents changed +29.0% from the comparable as-filed period.
$322.7M→$416.2M3 prior comparisons
Operating income increased 23.9%
Operating income changed +23.9% from the comparable as-filed period.
-$94.5M→-$71.9M2 prior comparisons
Gross profit increased 36.1%
Gross profit changed +36.1% from the comparable as-filed period.
$246.3M→$335.1M2 prior comparisons
Current liabilities increased 30.5%
Current liabilities changed +30.5% from the comparable as-filed period.
$1.1B→$1.4B3 prior comparisons
Research & development increased 37.7%
Research & development changed +37.7% from the comparable as-filed period.
$92.1M→$126.9M2 prior comparisons
Operating cash flow increased 18.7%
Operating cash flow changed +18.7% from the comparable as-filed period.
$64.7M→$76.8M3 prior comparisons
Free-cash-flow proxy increased 16.4%
Free-cash-flow proxy changed +16.4% from the comparable as-filed period.
$61.2M→$71.2M3 prior comparisons
Working capital / assets moved 515 bp lower
Working capital / assets changed -515 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
36.36%→31.21%3 prior comparisons
Free-cash-flow proxy increased 110.3%
Free-cash-flow proxy changed +110.3% from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes.
$36.8M→$77.4M5 prior comparisons
Operating cash flow increased 106.0%
Operating cash flow changed +106.0% from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes.
$39.7M→$81.7M5 prior comparisons
Inventory increased 53.6%
Inventory changed +53.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
$4.6M→$7.0M8 prior comparisons
Operating income increased 43.5%
Operating income changed +43.5% from the comparable as-filed period. The change ranks at the 22th percentile of 9 prior comparable changes.
-$93.1M→-$52.6M9 prior comparisons
Revenue increased 39.0%
Revenue changed +39.0% from the comparable as-filed period. The change ranks at the 33th percentile of 9 prior comparable changes.
$278.5M→$387.1M9 prior comparisons
Operating margin moved 1983 bp higher
Operating margin changed +1983 basis points from the comparable as-filed period. The change ranks at the 22th percentile of 9 prior comparable changes.
-33.43%→-13.60%9 prior comparisons
Net income increased 59.0%
Net income changed +59.0% from the comparable as-filed period. The change ranks at the 44th percentile of 9 prior comparable changes.
-$102.1M→-$41.9M9 prior comparisons
Cash & equivalents increased 51.2%
Cash & equivalents changed +51.2% from the comparable as-filed period. The change ranks at the 62th percentile of 16 prior comparable changes.
$284.0M→$429.4M16 prior comparisons
Gross profit increased 43.0%
Gross profit changed +43.0% from the comparable as-filed period. The change ranks at the 56th percentile of 9 prior comparable changes.
$218.0M→$311.8M9 prior comparisons
Gross margin moved 227 bp higher
Gross margin changed +227 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 9 prior comparable changes.
78.28%→80.55%9 prior comparisons
Research & development increased 39.8%
Research & development changed +39.8% from the comparable as-filed period. The change ranks at the 44th percentile of 9 prior comparable changes.
$81.8M→$114.3M9 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.